Go back

Webinar: Challenges and opportunities in Regenerative Medicine

The European Academies’ Science Advisory Council (EASAC)

and the Federation of European Academies of Medicine (FEAM)

cordially invite you to a joined  WEBINAR

on September 15th (11:00 AM to 12:30 PM CET)

to present and discuss their most recent joint report on

Challenges and potential in regenerative medicine



11:00 AM: Welcome and Introduction to the topic and EASAC & FEAM

  • Professor George Griffin, FEAM President
  • Professor Volker ter Meulen, Chairman EASAC Biosciences Steering Panel

11:15 AM: Presentation on the Project
Dr. Robin Fears, EASAC Biosciences Programme Director

11:30 AM: Presentation on the Report – Examples and Recommendations
Professor Giulio Cossu, University of Manchester

11:45 AM: Discussion with panelists and audience

moderated by Dr. Rosa Castro, Senior Scientific Policy Officer, FEAM

  • Patrick Celis, Scientific Administrator, European Medicines Agency
  • Thomas Bols, PTC Therapeutics, representing EUCOPE
  • Dr. Cor Oosterwijk, CEO, National Patient Alliance for Rare and Genetic Diseases, The Netherlands

12:25 PM: Closing


What is the Report about?

Regenerative medicine comprises various novel approaches to health care, representing a complex and heterogeneous group of products, including those based on cell and gene therapy, aimed at tissue regeneration and repair.

In this report, the European Academies’ Science Advisory Council (EASAC) and the Federation of European Academies of Medicine (FEAM) explore opportunities and challenges for regenerative medicine in the EU, focusing particularly on stem cells but also drawing more general conclusions for the field, with the objective of raising awareness and catalysing action by the scientific community, regulators, health services and public policy-makers. Read more on the report in the link provided above or in the press release


Use the following link to join the webinar: https://us02web.zoom.us/j/85093390433


Registration is not required




Subscribe to our newsletter